Drug intelligence / Profile preview

Gongning Granules

Development stage: Unknown
Lead developer: Beijing Foyou Pharmaceutical
Administration: Oral

Overview

Gongning Granules (宫宁颗粒) is a traditional Chinese medicine (TCM) developed and manufactured by Beijing Foyou Pharmaceutical. It is approved in China for the treatment of gynecological conditions characterized by abnormal uterine bleeding, such as excessive menstruation (menorrhagia) and prolonged menstrual periods. The product is particularly indicated for bleeding complications related to the use of intrauterine devices (IUDs). As a TCM granule formulation, it typically consists of a proprietary blend of herbal extracts designed to regulate blood flow and achieve hemostasis according to traditional therapeutic principles.

Brand names: Gongning宫宁
Other names: Gongning Granules宫宁颗粒

Targets

ESR1 (ERα)IGF-1 (Insulin-like growth factor 1)

Beyond the preview

Go deeper on Gongning Granules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gongning Granules.

Explore the full profile